Amgen, AstraZeneca Score With Tezspire; Can They Take On Dupixent?

Amgen and AstraZeneca's drug, Tezspire, scored Thursday in an esophageal disease that affects an estimated 470,000 patients in the U.S. The post Amgen, AstraZeneca Score With Tezspire; Can They Take On Dupixent? appeared first on Investor's Business Daily.